Mind Medicine News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.08.21	MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium (PR Newswire)
17.08.21	MindMed Joins Critical Path Institute's Patient-Reported Outcome Consortium (PR Newswire)
13.08.21	MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline (PR Newswire)
13.08.21	MindMed Announces 2021 Q2 Financial Results; Cash Balance of $157 USD Million ($195 CAD Million) to Execute on Diverse Clinical Pipeline (PR Newswire)
10.08.21	MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board (PR Newswire)
10.08.21	MindMed Appoints Dr. Robert Dworkin to Scientific Advisory Board (PR Newswire)
03.08.21	MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology (PR Newswire)
03.08.21	MindMed Joins Digital Medicine Society to Improve Health Outcomes and Equity Using Technology (PR Newswire)
28.07.21	MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT (PR Newswire)
28.07.21	MindMed Announces Initiation of Phase 1 Clinical Trial of Intravenous DMT (PR Newswire)
12.07.21	MindMed Chosen to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit (PR Newswire)
12.07.21	MindMed Chosen to Participate in Cowen's Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit (PR Newswire)
08.07.21	MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company (PR Newswire)
08.07.21	MindMed Announces Partnership with Datavant, a Leading Health Data Connectivity Company (PR Newswire)
28.06.21	MindMed Included in FTSE Russell 3000® Index (PR Newswire)
28.06.21	MindMed Included in FTSE Russell 3000® Index (PR Newswire)
23.06.21	MindMed Appoints MGH Psychiatrist-in-Chief Dr. Maurizio Fava to Scientific Advisory Board (PR Newswire)
23.06.21	MindMed Appoints MGH Psychiatrist-in-Chief Dr. Maurizio Fava to Scientific Advisory Board (PR Newswire)
17.06.21	MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board (PR Newswire)
17.06.21	MindMed Appoints Pharmaceutical Veteran Peter Bergethon, M.D. to Scientific Advisory Board (PR Newswire)
09.06.21	MindMed Announces Chief Executive Officer Transition (PR Newswire)
09.06.21	MindMed Announces Chief Executive Officer Transition (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Mind Medicine (MindMed) Inc Registered Shs Subordinated Voting

Aktien Top/Flop

Meistgelesene Nachrichten